OKLAHOMA CITY, Nov. 3 /PRNewswire-FirstCall/ -- PD-Rx Pharmaceuticals, Inc. (OTC Pink Sheets: PDRX), a publicly held corporation, has developed an Internet Portal for all of its customers to monitor, track and review all transactions of regulated and controlled substances with PD-Rx Pharmaceuticals. PD-Rx now offers a complete on-line web access port, that allows each and every customer to log on to the PD-Rx web based infrastructure to view current formularies, prices, invoices, pedigrees, shipments, tracking numbers, and perform order entry functions. The Internet Portal will allow the customer base the opportunity to interact with the same software platform that each employee uses at PD-Rx to process orders and review customer details. This portal will provide PD-Rx with the unique ability to handle a larger number of accounts and transactions in the future. Mr. William Hardy, Network Administrator for PD-Rx, states, "The Web Portal interfaces directly with our accounting system, allowing our customers to order online, retrieve past invoices, and see when their orders have shipped. This new service allows us to reach a higher level of customer service while reducing our operating cost." PD-Rx plans to continue the computerization and automation of the plant operations to keep up with operational costs and the many new requirements imposed by state and federal regulations as it pertains to validating customers and tracking shipments of regulated and controlled substances. ABOUT THE COMPANY PD-Rx offers pharmaceutical and management strategies to the healthcare industry. Our management strategies focus on new products, solid business partners, and the specialized segment of the pharmaceutical industry. As a licensed FDA manufacturer and packager, PD-Rx offers a full spectrum of medications and specialized services. Our goal is to develop a matrix of cost containment tools and products that we can merge into any healthcare network to enhance patient care and improve managed care organizations bottom line. We provide proprietary products and prepackaged medications that are viewed by patients, insurance payers, and healthcare providers as a progressive and responsive practice. This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward- looking statements involve known and unknown risks and uncertainties or other factors, which may cause actual results, performance or achievements expressed or implied by such forward-looking statements to vary from those forecast or implied in this release. Factors that might cause such a difference include, without limitation, decline in demand for the company's products or services, and the effect of general economic conditions and factors affecting the industry. DATASOURCE: PD-Rx Pharmaceuticals, Inc. CONTACT: Jack L. McCall, EVP & COO of PD-Rx Pharmaceuticals, Inc., +1-405-942-3040

Copyright